Latest news and thought leadership
The latest from Deallus pharmaceutical and life science industry experts
Brain Awareness Week 2025
Brain Awareness Week is a global campaign held every March that aims to increase public support and excitement for brain science. One of its core objectives is to educate the broader public about the impact of brain science on everyday lives.
GlobalData announces acquisition of market leading competitive intelligence solutions provider Deallus
GlobalData Plc, a London-based leading data and analytics company, has completed the acquisition of Deallus from private equity firm Archimed. Deallus is a London-based market-leading competitive intelligence solutions provider focused on the global life sciences sector.
Uncertainty is here to stay
Another turbulent year is ending, marked by economic, geopolitical, and technological shifts. With six decades behind me, I embrace this uncertainty as the norm. What does this mean for corporate decisions, especially in Pharma?
Season’s Greetings
From all of us at Deallus we wish all our clients, colleagues and friends a very peaceful and prosperous festive season.
The Migraine unveiling: Bringing the invisible disability to light
Globally, headache disorders affected approximately 40% of the population, or 3.1 billion people in 2021. A migraine attack goes beyond a severe headache; it is a constellation of symptoms that may include neck pain, nausea, dizziness, visual disturbances and sensitivity to light, sounds and smell among a variety of other manifestations.
Applications of AI in Pharma and the Life Sciences industry
Decoding the use of ChatGPT - and similar LLM applications - after the dust settles: Applications of AI in Pharma and the Life Sciences industry